Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference

PITTSBURGH, March 05, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ:KRYS), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that Krish Krishnan, Chief Executive Officer, will present a corporate overview and business update at the ROTH Capital Markets Growth Conference, taking place March 11-13 at the Ritz Carlton hotel in Laguna Niguel, California.

30^th Annual ROTH Conference
Date: Monday, March 12
Time: 10:30am Pacific Time
Location:  Ritz Carlton Hotel, Salon 6
Webcast: http://wsw.com/webcast/roth32/krys/

About Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS) is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. For more information, please visit http://www.krystalbio.com. 

CONTACT
Ashley R. Robinson 
LifeSci Advisors
arr@lifesciadvisors.com